FDA Drug Recalls

Recalls / Class II

Class IID-1389-2019

Product

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release Tablets, USP, Allergy & Congestion, 30-count box. Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India. UPC 3 11917 19454 7

Affected lot / code info
Lot: GKS1014, EXP 09/2019; GKT0484A, EXP 04/2020

Why it was recalled

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Recalling firm

Firm
Sun Pharmaceutical Industries, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
270 Prospect Plains Rd, N/A, Cranbury, New Jersey 08512-3605

Distribution

Quantity
14,399 30-count units
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2019-06-05
FDA classified
2019-06-14
Posted by FDA
2019-06-26
Terminated
2021-01-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1389-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.